vantuylen

[From Mother Jones, Gabrielle Canon, Saul Bromberger and Sandra Hoover, Dec 1, 2014] Light filtered in through shaded windows, casting shadows over Larry Hawkins’ bed. His room was often kept dark. In the final throes of his battle with AIDS, he was sensitive to brightness. There was just enough light for photographers Saul Bromberger and Sandy Hoover to […]

[From BMJ, Anne Gulland, Nov 20, 2014] The AIDS epidemic can be stopped by 2030, despite only 38% of adults with HIV or AIDS currently having access to antiretroviral drugs, a new report by the Joint United Nations Programme on HIV and AIDS (UNAIDS) has said. UNAIDS estimated that 13.6 million people with HIV or AIDS

[From Medscape, Pam Harrison, Nov 6, 2014] The virologic responses with reduced-dose efavirenz at 48 weeks have proven durable out to 96 weeks, ENCORE1 study results show. The finding, presented at the HIV Drug Therapy Congress in Glasgow, United Kingdom, supports the use of a lower dose of the drug in combination with tenofovir plus

[From International AIDS Society, Mark Mascolini, Nov 13, 2014] Markers of gut epithelial barrier integrity, immune activation, inflammation, and coagulation predicted mortality in a case-control study of a US cohort responding to antiretroviral therapy (ART). Previous research showed that heightened inflammation predicts mortality in HIV-positive people taking ART. Because less is known about the prognostic value